Next Article in Journal
Delivery of Cancer Therapeutics Using Nanotechnology
Next Article in Special Issue
Design and Exploratory Neuropharmacological Evaluation of Novel Thyrotropin-Releasing Hormone Analogs and Their Brain-Targeting Bioprecursor Prodrugs
Previous Article in Journal / Special Issue
Preclinical Absorption, Distribution, Metabolism, and Excretion of an Oral Amide Prodrug of Gemcitabine Designed to Deliver Prolonged Systemic Exposure
Pharmaceutics 2013, 5(2), 277-293; doi:10.3390/pharmaceutics5020277

Encapsulation of Hydrocortisone and Mesalazine in Zein Microparticles

, 1,2
, 1,2
, 3
, 3
, 4
, 5
 and 1,4,*
Received: 4 February 2013 / Revised: 29 April 2013 / Accepted: 3 May 2013 / Published: 10 May 2013
(This article belongs to the Special Issue Prodrugs)
View Full-Text   |   Download PDF [682 KB, uploaded 10 May 2013]   |   Browse Figures
Abstract: Zein was investigated for use as an oral-drug delivery system by loading prednisolone into zein microparticles using coacervation. To investigate the adaptability of this method to other drugs, zein microparticles were loaded with hydrocortisone, which is structurally related to prednisolone; or mesalazine, which is structurally different having a smaller LogP and ionizable functional groups. Investigations into the in vitro digestibility, and the electrophoretic profile of zein, and zein microparticles were conducted to shed further insight on using this protein as a drug delivery system. Hydrocortisone loading into zein microparticles was comparable with that reported for prednisolone, but mesalazine loading was highly variable. Depending on the starting quantities of hydrocortisone and zein, the average amount of microparticles equivalent to 4 mg hydrocortisone, (a clinically used dose), ranged from 60–115 mg, which is realistic and practical for oral dosing. Comparatively, an average of 2.5 g of microparticles was required to deliver 250 mg of mesalazine (a clinically used dose), so alternate encapsulation methods that can produce higher and more precise mesalazine loading are required. In vitro protein digestibility revealed that zein microparticles were more resistant to digestion compared to the zein raw material, and that individual zein peptides are not preferentially coacervated into the microparticles. In combination, these results suggest that there is potential to formulate a delivery system based on zein microparticles made using specific subunits of zein that is more resistant to digestion as starting material, to deliver drugs to the lower gastrointestinal tract.
Keywords: maize; microparticles; protein; drug loading; in vitro digestibility; electrophoresis maize; microparticles; protein; drug loading; in vitro digestibility; electrophoresis
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |

MDPI and ACS Style

Lau, E.T.L.; Giddings, S.J.; Mohammed, S.G.; Dubois, P.; Johnson, S.K.; Stanley, R.A.; Halley, P.J.; Steadman, K.J. Encapsulation of Hydrocortisone and Mesalazine in Zein Microparticles. Pharmaceutics 2013, 5, 277-293.

AMA Style

Lau ETL, Giddings SJ, Mohammed SG, Dubois P, Johnson SK, Stanley RA, Halley PJ, Steadman KJ. Encapsulation of Hydrocortisone and Mesalazine in Zein Microparticles. Pharmaceutics. 2013; 5(2):277-293.

Chicago/Turabian Style

Lau, Esther T.L.; Giddings, Steven J.; Mohammed, Salmaan G.; Dubois, Paul; Johnson, Stuart K.; Stanley, Roger A.; Halley, Peter J.; Steadman, Kathryn J. 2013. "Encapsulation of Hydrocortisone and Mesalazine in Zein Microparticles." Pharmaceutics 5, no. 2: 277-293.

Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert